Target Audience and Goal Statement
This activity is intended for dermatologists, plastic surgeons, and other clinicians involved in aesthetic medicine.
The goal of this activity is to explore how to build an aesthetic practice that balances the art, science, and business of
aesthetic medicine.
Upon completion of this activity, participants will be able to:
- Describe strategies for balancing medical and aesthetic practice
- Review techniques for initiating discussions with patients about aesthetic treatment options
- Discuss practical tips for the smooth running of an aesthetic practice
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Moderator

-
Jeffrey S. Dover, MD
Director, SkinCare Physicians, Chestnut Hill, Massachusetts; Associate Clinical Professor, Yale University School of Medicine,
New Haven, Connecticut; Adjunct Professor of Medicine, Dartmouth Medical School, Hanover, New Hampshire; Adjunct Associate
Professor of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
Disclosures
Disclosure: Jeffrey S. Dover, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: IRIDEX Corporation; Lumenis; Medicis Pharmaceutical Corporation; Real Aesthetics;
Solta Medical; Zeltiq Aesthetics, Inc.
Served as a speaker or a member of a speakers bureau for: Allergan, Inc; Boston Biocom; Cynosure, Inc.; Iridex Corporation;
Kythera Biopharmaceuticals; Lumenis; Medicis Pharmaceutical Corporation; Merz Pharmaceuticals; Palomar Medical Technologies;
Real Aesthetics; Shaser, Inc; Solta Medical; Syneron Medical Ltd; Zeltiq Aesthetics, Inc.
Has received the use of equipment from: Lumenis; Opusmed, Inc; Palomar Medical Technologies; Solta Medical; Syneron Medical
Ltd.
Owns stock, stock options, or bonds from: CVS/Skin Effects, Shaser Inc.
Dr Dover does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Dover does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Panelists

-
Michael H. Gold, MD
Medical Director, Gold Skin Care Center, Tennessee Clinical Research Center; Associate Clinical Professor of Dermatology,
Vanderbilt University School of Medicine, Nashville, Tennessee
Disclosures
Disclosure: Michael H. Gold, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan, Inc.; Merz Aesthetics; Alma Lasers; Lumiere Medical; Venus Concept; Obagi Medical Products, Inc.; Pacific Bioscience Laboratories, Inc./L'Oréal; Ellman International, Inc.; Biopelle, Inc.; Neocutis Inc.; Aqua Pharmaceuticals; LEO Pharma, Inc.
Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; LEO Pharma, Inc.; Alma Lasers; Cutera, Inc.; Lumiere
Medical; Ellman International, Inc.; Venus Concept; Syneron Medical Ltd; Lumenis; Obagi Medical Products, Inc.; Biopelle,
Inc.; PrecisionMD; Neocutis Inc.; Medicis Pharmaceutical Corporation; Cynosure, Inc.; Sandstone Medical Technologies; Solta
Medical; Ulthera, Inc.; Aqua Pharmaceuticals; Abbott Laboratories
Received grants for clinical research from: Dow Pharmaceutical Sciences; NB Therapeutics; DUSA Pharmaceuticals, Inc.; Pollogen
Ltd.; Photocure Inc; Kythera Biopharmaceuticals; Medicis Pharmaceutical Corporation; Amgen Inc.; Alma Lasers; Abbott Laboratories;
Perrigo Company; Taro Pharmaceutical Industries; Glenmark; Lithera; Biopelle, Inc.; Ulthera, Inc.; Syneron Medical Ltd; Galderma
Laboratories; L.P.; Merz Pharmaceuticals; Tolmar Inc.; Allergan, Inc. Has received the use of equipment from: Ellman International,
Inc.; Syneron Medical Ltd; Ulthera, Inc.; Venus Concept; Lumenis; Alma Lasers
Owns stock, stock options, or bonds in: DUSA Pharmaceuticals, Inc.; Lumenis; Sciton, Inc.; Venus Concept; Lumiere Medical
Dr Gold does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Gold does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

-
Kavita Mariwalla, MD
Assistant Clinical Professor, Columbia University, New York, New York; Assistant Professor, State University of New York,
Stony Brook, New York
Disclosures
Disclosure: Kavita Mariwalla, MD, has disclosed no relevant financial relationships.
Dr Mariwalla does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.
Dr Mariwalla does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Editors
CME Reviewer(s)
-
Laurie E. Scudder, DNP, NP
Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing
and Allied Health, George Washington University, Washington, DC
Disclosures
Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.
Accreditation Statements
For Physicians

-
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Medscape, LLC designates this enduring material for a maximum of 1.00
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.